Friday, December 20, 2013 12:54:19 PM
It was .002 bottom for 18 months, and was thin to .01 the entire time, with no volume for 18 months. The OS is now about 245,000 shares rounded off. R/S with the R/M was 500:1 R/S.
They paid off debt before the R/S with shares that also got R/S.
The group that got those shares for cash to pay off the debt own about 48% of the float now.
I own 1%. I will buy more under $4 if I get the chance. It is my hope that they will pump the stock to $20 before any float dilution or even before raising cash. They have a complex share structure, multiple preferred share classes. It was structured to raise cash for acquisitions of university biotech patents....and to be operated like a public, venture capital incubator bridge funding firm.
I should add that the Spotlight investors that bought AEXP in the R/M (my guess is that is the CEO), got about 7.5 million restricted shares, that are not in the float.
So if they get the stock to $10/share with news, that gives it a 75 Mil $ market cap to raise private biotech investor funds.
They paid off debt before the R/S with shares that also got R/S.
The group that got those shares for cash to pay off the debt own about 48% of the float now.
I own 1%. I will buy more under $4 if I get the chance. It is my hope that they will pump the stock to $20 before any float dilution or even before raising cash. They have a complex share structure, multiple preferred share classes. It was structured to raise cash for acquisitions of university biotech patents....and to be operated like a public, venture capital incubator bridge funding firm.
I should add that the Spotlight investors that bought AEXP in the R/M (my guess is that is the CEO), got about 7.5 million restricted shares, that are not in the float.
So if they get the stock to $10/share with news, that gives it a 75 Mil $ market cap to raise private biotech investor funds.
Ambition with out knowledge is like ship in dry dock. Going nowhere fast!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
